NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹73 Cr | ₹60 Cr | ₹58 Cr | ₹57 Cr | ₹60 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹73 Cr |
Mar2024 | ₹60 Cr |
Mar2023 | ₹58 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹60 Cr |
How is Deferred Tax Assets / Liabilities of NEULAND LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹73 Cr | 20.49 | |
Mar2024 | ₹60 Cr | 3.67 | |
Mar2023 | ₹58 Cr | 2.82 | |
Mar2022 | ₹57 Cr | -5.12 | |
Mar2021 | ₹60 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹17,224.7 Cr | -3% | -2.8% | 7.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -3% |
-2.8% |
7.7% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses